tiprankstipranks
Omega Therapeutics, Inc. (OMGA)
:OMGA
US Market

Omega Therapeutics (OMGA) Income Statement

Compare
457 Followers

Omega Therapeutics Income Statement

Last quarter (Q3 2024), Omega Therapeutics's total revenue was $2.61M, an increase of 214.32% from the same quarter last year. In Q3, Omega Therapeutics's net income was $-16.44M. See Omega Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 3.09M$ 2.07M$ 144.00K$ 0.00$ 0.00
Gross Profit
$ -62.77M$ -3.12M$ -1.24M$ -1.15M$ -794.00K
Operating Expenses
$ 103.36M$ 104.84M$ 66.18M$ 28.64M$ 17.34M
Depreciation and Amortization
$ 6.77M$ 5.19M$ 1.39M$ 1.15M$ 794.00K
EBITDA
$ -93.49M$ -97.58M$ -64.64M$ -27.50M$ -16.55M
Operating Income
$ -100.26M$ -102.77M$ -66.03M$ -28.64M$ -17.34M
Other Income/Expenses
$ 2.83M$ 65.00K$ -2.25M$ -802.00K$ -606.00K
Pretax Income
$ -97.43M$ -102.70M$ -68.28M$ -29.45M$ -17.95M
Net Income
$ -97.43M$ -102.64M$ -69.16M$ -30.20M$ -18.53M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.80$ -2.14$ -1.45$ -0.63$ -0.39
Diluted EPS
$ -1.80$ -2.14$ -1.45$ -0.63$ -0.39
Weighted Average Shares Outstanding
54.01M 47.88M 47.79M 47.84M 47.84M
Weighted Average Shares Outstanding (Diluted)
54.01M 47.88M 47.79M 47.84M 47.84M
Currency in USD

Omega Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis